With the support of the National Institute on Drug Abuse, scientists at Wake Forest School of Medicine have been working to find a safe, non-addictive pain killer to help fight the current opioid crisis in this country.
And they may have done just that, though in an animal model.
Known as AT-121, the new chemical compound has dual therapeutic action that suppressed the addictive effects of opioids and produced morphine-like analgesic effects in non-human primates.
“In our study, we found AT-121 to be safe and non-addictive, as well as an effective pain medication,” said Mei-Chuan Ko, Ph.D., professor of physiology and pharmacology at the School of Medicine, part of Wake Forest Baptist Medical Center.
“In addition, this compound also was effective at blocking abuse potential of prescription opioids, much like buprenorphine does for heroin, so we hope it could be used to treat pain and opioid abuse.”
The findings are published in the Aug. 29 issue of the journal Science Translational Medicine.
The main objective of this study was to design and test a chemical compound that would work on both the mu opioid receptor, the main component in the most effective prescription pain killers, and the nociceptin receptor, which opposes or blocks the abuse and dependence-related side effects of mu-targeted opioids. Current opioid pain drugs, such as fentanyl and oxycodone, work only on the mu opioid receptor, which also produces unwanted side effects – respiratory depression, abuse potential, increased sensitivity to pain and physical dependence.
“We developed AT-121 that combines both activities in an appropriate balance in one single molecule, which we think is a better pharmaceutical strategy than to have two drugs to be used in combination,” Ko said.
In the study, the researchers observed that AT-121 showed the same level of pain relief as an opioid, but at a 100-times lower dose than morphine. At that dose, it also blunted the addictive effects of oxycodone, a commonly abused prescription drug.
The bifunctional profile of AT-121 not only gave effective pain relief without abuse potential, it also lacked other opioid side-effects that patients typically struggle with, such as itch, respiratory depression, tolerance and dependence.
“Our data shows that targeting the nociceptin opioid receptor not only dialed down the addictive and other side-effects, it provided effective pain relief,” Ko said. “The fact that this data was in nonhuman primates, a closely related species to humans, was also significant because it showed that compounds, such as AT-121, have the translational potential to be a viable opioid alternative or replacement for prescription opioids.”
Next steps include conducting additional preclinical studies to collect more safety data, and then if all goes well, applying to the Food and Drug Administration for approval to begin clinical trials in people, Ko said.
The Latest on: Non-addictive pain killer
via Google News
The Latest on: Non-addictive pain killer
- Specialty Coatings Market 2019-2028 With Major Players Landscape and Their Business Strategieson November 15, 2019 at 12:15 am
simple format for few years and an individual section on Specialty Coatings market recent development such as collaboration, acquisition, mergers, and any new service or new product launching in the ...
- This Might Be the Comfiest Coat You Can Buy on Amazonon November 14, 2019 at 4:17 pm
... coat from Prettygarden is the retail giant’s number one best-selling faux fur coat, and it only costs $32. The jacket features a fuzzy lapel, two side pockets, and elastic cuffs for an ...
- This parka from Everlane is my go-to for freezing cold weather — and it's made with 100% recycled materialon November 14, 2019 at 2:13 pm
Everlane's ReNew Long Puffer is a warm parka at an affordable price. Plus, it's made out of recycled plastic bottles.
- Crystal coatings could help solve mystery of fracture patternson November 14, 2019 at 7:35 am
The crystal coatings may also influence the fracturing process itself ... "We suspect that probably a whole generation of observational and experimental work is needed, either with analog materials or ...
- Smart Coatings Market 2019 Global Analysis, Size, Share, Growth, Trends & Forecast To 2025on November 13, 2019 at 3:52 am
The beneficial self-healing and self-repair properties of smart coatings make them highly suitable for material protection, corrosion protection, and other surface quality improvement applications.
- Bioactive coating of zirconia toughened alumina ceramic implants improves cancellous osseointegrationon November 13, 2019 at 2:12 am
The coating (1 nm thickness) is stable against chemical and ... Even in comparison to the gold standard of titanium material used in another study with cylindrical implants with rough or coated ...
- Eastman collaborates with NB Coatings to offer sustainable automotive plasticon November 12, 2019 at 4:26 pm
Trēva has low VOC emissions, which is critical for interior parts. Its processing ease and excellent flow enable good dimensional stability and thin-wall designs for less material usage and lower ...
- Denatured lysozyme-coated carbon nanotubes: a versatile biohybrid materialon November 12, 2019 at 2:05 am
and to allow the efficient exfoliation of the popular 2D-materials molybdenum disulfide and graphene 37. Here, we show that AP-LYS is able to promote the debundling of multiwalled CNTs (MWNTs) as well ...
- Polyurea Coatings Market Inclinations And Development Status Highlighted During Forecast Period 2019-2025on November 12, 2019 at 12:14 am
The polyurea coating Industry classified on the bases of type, raw material, technology, application, and region. Based on the type, the polyurea coating Industry divided into pure polyurea and hybrid ...
- Haining Duletai New Material Co., Ltd Introduces PVC Coated Membrane structure For Roofing, Tents & Other Applicationson November 11, 2019 at 4:48 am
Besides the 100% high-tenacity polyester Membrane structure, Haining Duletai New Material Co., Ltd also offers a wide range of roller shade fabrics for the solar protection of buildings. With their ...
via Bing News